SMALL CAP SIREN

Friday, November 6, 2026

SEC distress filings for November 6, 2026: Adicet Bio, COGNITION THERAPEUTICS, Tempest Therapeutics

Three filings from small caps that hit EDGAR on November 5, 2026 and November 6, 2026, each with one factual line and a link to the source. Summaries of public SEC filings, not investment advice. Always read the filing.

  1. Adicet Bio, Inc. ($ACET)
    First-time going-concern language · 10-Q filed Nov 5, 2026

    Adicet Bio's 10-Q for the period ended September 30, 2026 includes 'substantial doubt' going-concern language, the first such language in its filings over the prior 18 months.

    Read the filing on sec.gov →
  2. COGNITION THERAPEUTICS INC ($CGTX)
    Bid-price deficiency notice (8-K Item 3.01) · 8-K filed Nov 5, 2026

    COGNITION THERAPEUTICS says it received a Nasdaq notice on November 3, 2026 that it does not meet the $1.00 minimum bid price requirement; it has until May 3, 2027 to regain compliance.

    Read the filing on sec.gov →
  3. Tempest Therapeutics, Inc. ($TPST)
    Bid-price deficiency notice (8-K Item 3.01) · 8-K filed Nov 6, 2026

    Tempest Therapeutics says it received a Nasdaq notice on November 4, 2026 that it does not meet the $1.00 minimum bid price requirement; it has until May 3, 2027 to regain compliance.

    Read the filing on sec.gov →

Deadline watch: next 30 days

Every open Nasdaq and NYSE listing notice: smallcapsiren.com/delisting-tracker

Also flagged

Explainer: What a non-reliance 8-K (Item 4.02) means

A company files an 8-K under Item 4.02 when its board, an audit committee, or its auditor concludes that financial statements it already published should no longer be relied upon because of an error. The filing names the periods affected and usually describes the issue. Corrected numbers come later, in a restated or amended report.

Get the full list free, every weekday at 7 AM ET

Today's full issue flagged 55 filings: auditor changes, restatements, delisting notices, bankruptcies and going-concern language, each linked to EDGAR. It's free, one email each weekday.

Unsubscribe anytime in one click. Not investment advice. See a sample issue →

← Previous day · All daily top 3s